{
    "nctId": "NCT05872412",
    "briefTitle": "Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer",
    "officialTitle": "Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Triple Negative Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 82,
    "primaryOutcomeMeasure": "Pathological complete response rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Triple-negative breast cancer\n* Stage II and III\n\nExclusion Criteria:\n\n* Double primaries\n* Male breast cancer\n* Pregnant or lactating women\n* Patients with Eastern Cooperative Oncology Group (ECOG) performance status more than two\n* Patients below 18 years old\n* Initial surgery of the primary site (excluding diagnostic biopsy)\n* Serious concomitant medical illness including clinically significant cardiovascular disease\n* Major surgery or trauma in the previous four weeks",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}